Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Author's Avatar
Feb 13, 2021
Article's Main Image

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules.